• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Patient care protocols and personal safety measures for health care professionals in cardiac catheterization rooms during the COVID-19 outbreak in the National Institute of Cardiology.国家心脏病研究所 COVID-19 疫情期间心导管室医护人员的患者护理方案和个人安全措施。
Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E686-E691. doi: 10.1002/ccd.28979. Epub 2020 Jun 1.
2
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.EAPCI 关于 COVID-19 大流行期间急性冠状动脉综合征侵袭性管理的立场声明。
EuroIntervention. 2020 Jun 25;16(3):233-246. doi: 10.4244/EIJY20M05_01.
3
Management Trends in the Cath Lab During the COVID-19 Period, an Egyptian Survey.COVID-19 期间心导管室的管理趋势:埃及调查。
Curr Probl Cardiol. 2021 Mar;46(3):100715. doi: 10.1016/j.cpcardiol.2020.100715. Epub 2020 Sep 24.
4
Patient care protocols in cardiac catheterization rooms during the COVID-19 outbreak.新冠疫情期间心脏导管室的患者护理方案。
Arch Cardiol Mex. 2020;90(Supl):45-49. doi: 10.24875/ACM.M20000066.
5
Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During the Novel Coronavirus SARS-CoV-2 (COVID-19) Pandemic: A U.S. Multi-Institutional Perspective.新型冠状病毒SARS-CoV-2(COVID-19)大流行期间小儿及先天性心脏病心导管插入术的资源分配与决策:美国多机构视角
J Invasive Cardiol. 2020 May;32(5):E103-E109. doi: 10.25270/jic/20.00189. Epub 2020 Apr 9.
6
Management of Structural Heart Disease and Acute Coronary Syndromes in the COVID-19 Pandemic.COVID-19 大流行期间结构性心脏病和急性冠状动脉综合征的管理。
Curr Atheroscler Rep. 2020 Jun 10;22(7):29. doi: 10.1007/s11883-020-00849-5.
7
Non-Elective Pediatric Cardiac Catheterization During COVID-19 Pandemic: A New York Center Experience.新冠疫情期间的非选择性儿科心脏导管插入术:纽约中心的经验
J Invasive Cardiol. 2020 Jul;32(7):E178-E181. doi: 10.25270/jic/20.00324.
8
Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker?新型冠状病毒肺炎与心血管疾病:危险因素还是风险标志物?
Rev Med Virol. 2021 May;31(3):e2172. doi: 10.1002/rmv.2172. Epub 2020 Sep 22.
9
National Clinical Guidance for the Management of Cardiovascular Intervention in the COVID-19 Pandemic: From Bangladesh Society of Cardiovascular Interventions (BSCI).《2019年冠状病毒病大流行期间心血管介入治疗管理的国家临床指南》:来自孟加拉国心血管介入学会(BSCI)
Mymensingh Med J. 2020 Apr;29(2):488-494.
10
Care of acute coronary syndromes during the health contingency due to a SARS-CoV-2 outbreak.2019冠状病毒病疫情期间急性冠状动脉综合征的护理
Arch Cardiol Mex. 2020;90(Supl):33-35. doi: 10.24875/ACM.M20000062.

本文引用的文献

1
Impact of a 10 Rules Protocol on COVID-19 Hospital-Related Transmission: Insights From Padua University Hospital, Italy.“十条规则”方案对新冠肺炎医院内传播的影响:来自意大利帕多瓦大学医院的见解
Circ Cardiovasc Interv. 2020 May;13(5):e009279. doi: 10.1161/CIRCINTERVENTIONS.120.009279. Epub 2020 May 15.
2
Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During the Novel Coronavirus SARS-CoV-2 (COVID-19) Pandemic: A U.S. Multi-Institutional Perspective.新型冠状病毒SARS-CoV-2(COVID-19)大流行期间小儿及先天性心脏病心导管插入术的资源分配与决策:美国多机构视角
J Invasive Cardiol. 2020 May;32(5):E103-E109. doi: 10.25270/jic/20.00189. Epub 2020 Apr 9.
3
Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement.COVID-19 大流行期间结构性心脏病介入治疗转诊患者的分诊考虑:美国心脏病学会/心血管造影和介入学会立场声明。
Catheter Cardiovasc Interv. 2020 Sep 1;96(3):659-663. doi: 10.1002/ccd.28910. Epub 2020 Jun 8.
4
Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19.意大利介入心脏病学会(GISE)关于疑似、可能或确诊 COVID-19 病例情况下医疗保健提供者的导管实验室特定准备建议的立场文件。
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):839-843. doi: 10.1002/ccd.28888. Epub 2020 Apr 11.
5
CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic.《新型冠状病毒肺炎流行期间心血管急危重症患者临床管理专家共识》
Circulation. 2020 May 19;141(20):e810-e816. doi: 10.1161/CIRCULATIONAHA.120.047011. Epub 2020 Mar 27.
6
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.新型冠状病毒肺炎(COVID-19)大流行期间的心导管实验室考量:来自美国心脏病学会介入委员会和心血管造影和介入学会
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375. doi: 10.1016/j.jacc.2020.03.021. Epub 2020 Mar 19.
7
COVID-19 and Italy: what next?COVID-19 和意大利:下一步如何?
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
8
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.

国家心脏病研究所 COVID-19 疫情期间心导管室医护人员的患者护理方案和个人安全措施。

Patient care protocols and personal safety measures for health care professionals in cardiac catheterization rooms during the COVID-19 outbreak in the National Institute of Cardiology.

机构信息

Department of Interventional Cardiology, Ignacio Chavez National Institute of Cardiology, Mexico City, Mexico.

出版信息

Catheter Cardiovasc Interv. 2021 Apr 1;97(5):E686-E691. doi: 10.1002/ccd.28979. Epub 2020 Jun 1.

DOI:10.1002/ccd.28979
PMID:32478472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7300668/
Abstract

The COVID-19 was first described in late 2019 that quickly became a pandemic affecting every health system as we know it. The high transmissibility among humans represents a well-known high burden of morbidity and mortality not only for cardiovascular patients but also for a higher risk between health care professionals that must deliver high-quality care to them in any scenario, and cardiac catheterization rooms are no exception. This creates a new dilemma, minimize exposure to patients and health care professionals to COVID-19 while maintaining high quality in cardiovascular therapeutics. In order to achieve this, several international recommendations on treatment algorithms modifications and in safety measures in the catheterization room have been published, always aiming to solve this dilemma in the best possible way. Hereby, we present a summary of the most recent treatment algorithms in the most important cardiovascular interventions (acute coronary syndromes, structural and congenital heart diseases) as well as specific safety measures with a step-by-step preparedness before and after any interventional procedure during COVID-19 outbreak. The objective of this document is to inform and to train health care professionals that works in cardiac catheterization rooms on the risks as well on the plan for containment, mitigation, and response to the global situation of COVID-19 infection in order to apply this in their own local work environments.

摘要

COVID-19 于 2019 年底首次被描述,迅速成为一种大流行病,影响到我们所知道的每一个卫生系统。人与人之间的高传染性代表了众所周知的高发病率和死亡率负担,不仅对心血管病患者如此,对必须在任何情况下为他们提供高质量护理的医护人员来说也是如此,而心脏导管室也不例外。这带来了一个新的困境,即在为 COVID-19 患者和医护人员尽量减少暴露的同时,保持心血管治疗的高质量。为了实现这一目标,已经发布了几项关于治疗算法修改和导管室安全措施的国际建议,始终旨在以最佳方式解决这一困境。在此,我们总结了最重要的心血管介入治疗中(急性冠状动脉综合征、结构性和先天性心脏病)的最新治疗算法,以及在 COVID-19 爆发期间,在任何介入性手术前后的具体安全措施,逐步做好准备。本文件的目的是告知并培训在心脏导管室工作的医护人员有关风险以及遏制、减轻和应对 COVID-19 全球感染情况的计划,以便将其应用于他们自己的当地工作环境中。